Loading clinical trials...
Loading clinical trials...
Feasibility, Safety, Randomized, Controlled, Open-label Study to Evaluate the Neuroprotective Effect of Hemodialysis of Plasma Glutamate and Proinflammatory Cytokines in the Acute Phase of Ischemic Stroke
Conditions
Interventions
Hemodialysis
Locations
1
Spain
José Vivancos Mora, MD., PhD
Madrid, Spain
Start Date
January 1, 2021
Primary Completion Date
November 1, 2022
Completion Date
December 1, 2022
Last Updated
January 3, 2022
NCT05361187
NCT02038998
NCT03417349
NCT04870684
NCT04377022
NCT02587949
Lead Sponsor
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions